Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality.
Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality.
复制标题
在创始人队列中确定的肥厚相关多态性应用于心力衰竭风险和死亡率。
DOI:
10.1111/j.1752-8062.2010.00251.x
复制
发表时间:
2011-02
期刊:
影响因子:
--
通讯作者:
Liggett SB
中科院分区:
文献类型:
--
作者:
Parsa A;Chang YP;Kelly RJ;Corretti MC;Ryan KA;Robinson SW;Gottlieb SS;Kardia SL;Shuldiner AR;Liggett SB
A three-stage approach was undertaken using genome-wide, case-control, and case-only association studies to identify genetic variants associated with heart failure mortality. In an Amish founder population (n = 851), cardiac hypertrophy, a trait integral to the adaptive response to failure, was found to be heritable (h2 = 0.28, p = 0.0002) and GWAS revealed 21 candidate hypertrophy SNPs. In a case (n = 1,610)-control (n = 463) study in unrelated Caucasians, one of the SNPs associated with hypertrophy (rs2207418, p = 8 × 10−6), was associated with heart failure, RR = 1.85(1.25–2.73, p = 0.0019). In heart failure cases rs2207418 was associated with increased mortality, HR = 1.51(1.20–1.97, p = 0.0004). There was consistency between studies, with the GG allele being associated with increased ventricular mass (~13 g/m2) in the Amish, heart failure risk, and heart failure mortality. This SNP is in a gene desert of chromosome 20p12. Five genes are within 2.0 mbp of rs2207418 but with low LD between their SNPs and rs2207418. A region near this SNP is highly conserved in multiple vertebrates (lod score = 1,208). This conservation and the internal consistency across studies suggests that this region has biologic importance in heart failure, potentially acting as an enhancer or repressor element. rs2207418 may be useful for predicting a more progressive form of heart failure that may require aggressive therapy.
登录
查看更多内容
DOI:
10.1161/circgenetics.109.895995
发表时间:
2010-06
期刊:
Circulation. Cardiovascular genetics
影响因子:
--
作者:
Morrison AC;Felix JF;Cupples LA;Glazer NL;Loehr LR;Dehghan A;Demissie S;Bis JC;Rosamond WD;Aulchenko YS;Wang YA;Haritunians T;Folsom AR;Rivadeneira F;Benjamin EJ;Lumley T;Couper D;Stricker BH;O'Donnell CJ;Rice KM;Chang PP;Hofman A;Levy D;Rotter JI;Fox ER;Uitterlinden AG;Wang TJ;Psaty BM;Willerson JT;van Duijn CM;Boerwinkle E;Witteman JC;Vasan RS;Smith NL
通讯作者:
Smith NL
DOI:
10.1161/circgenetics.109.895763
发表时间:
2010-06
期刊:
Circulation. Cardiovascular genetics
影响因子:
--
作者:
Smith NL;Felix JF;Morrison AC;Demissie S;Glazer NL;Loehr LR;Cupples LA;Dehghan A;Lumley T;Rosamond WD;Lieb W;Rivadeneira F;Bis JC;Folsom AR;Benjamin E;Aulchenko YS;Haritunians T;Couper D;Murabito J;Wang YA;Stricker BH;Gottdiener JS;Chang PP;Wang TJ;Rice KM;Hofman A;Heckbert SR;Fox ER;O'Donnell CJ;Uitterlinden AG;Rotter JI;Willerson JT;Levy D;van Duijn CM;Psaty BM;Witteman JC;Boerwinkle E;Vasan RS
通讯作者:
Vasan RS
影响因子:
7
作者:
Siepel, A;Bejerano, G;Haussler, D
通讯作者:
Haussler, D
影响因子:
1.8
作者:
Pollin, Toni I.;McBride, Daniel J.;O'Connell, Jeffrey R.
通讯作者:
O'Connell, Jeffrey R.
影响因子:
5.3
作者:
Sorkin, J;Post, W;Shuldiner, AR
通讯作者:
Shuldiner, AR